These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 16902221

  • 1. Fluoroquinolone resistance in Salmonella Typhi.
    Cooke FJ, Wain J, Threlfall EJ.
    BMJ; 2006 Aug 12; 333(7563):353-4. PubMed ID: 16902221
    [No Abstract] [Full Text] [Related]

  • 2. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae.
    Crump JA, Barrett TJ, Nelson JT, Angulo FJ.
    Clin Infect Dis; 2003 Jul 01; 37(1):75-81. PubMed ID: 12830411
    [Abstract] [Full Text] [Related]

  • 3. Quinolone resistant enteric fever--problems and remedies.
    Rodrigues C, Mehta A, Joshi VR.
    J Assoc Physicians India; 1998 Aug 01; 46(8):751-2. PubMed ID: 11229301
    [No Abstract] [Full Text] [Related]

  • 4. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R, Desjardins M, McCarthy AE, Ramotar K, Jessamine P, Guibord C, Toye B.
    BMC Infect Dis; 2004 Sep 20; 4():36. PubMed ID: 15380025
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India.
    Bandyopadhyay R, Balaji V, Yadav B, Jasmine S, Sathyendra S, Rupali P.
    Trop Doct; 2018 Jul 20; 48(3):182-188. PubMed ID: 29495943
    [Abstract] [Full Text] [Related]

  • 6. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH, Khan MA.
    J Coll Physicians Surg Pak; 2008 Jan 20; 18(1):13-6. PubMed ID: 18452661
    [Abstract] [Full Text] [Related]

  • 7. Enteric fever treatment failures: a global concern.
    Chandel DS, Chaudhry R.
    Emerg Infect Dis; 2001 Jan 20; 7(4):762-3. PubMed ID: 11585550
    [No Abstract] [Full Text] [Related]

  • 8. Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi.
    Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, Misra A.
    BMC Infect Dis; 2005 May 18; 5():37. PubMed ID: 15904505
    [Abstract] [Full Text] [Related]

  • 9. Nalidixic acid-resistant Salmonella enterica serotype typhi infection presenting with sub-intestinal obstruction and mesenteric adenitis.
    Al-Khuwaitir TS, Al-Zuhair AA, Al-Ghamdi AG, Khan A.
    Saudi Med J; 2008 Jan 18; 29(1):129-32. PubMed ID: 18176688
    [Abstract] [Full Text] [Related]

  • 10. Is nalidixic acid resistance linked to clinical virulence in Salmonella enterica serovar Typhi infections?
    Kadhiravan T, Wig N, Renuka K, Kapil A, Kabra SK, Misra A.
    J Med Microbiol; 2008 Aug 18; 57(Pt 8):1046-1048. PubMed ID: 18628512
    [No Abstract] [Full Text] [Related]

  • 11. Nalidixic acid screening test for the detection of decreased susceptibility to ciprofloxacin in Salmonella typhi.
    Ciraj AM, Seema DS, Bhat GK, Shivananda PG.
    Indian J Pathol Microbiol; 2001 Oct 18; 44(4):407-8. PubMed ID: 12035350
    [No Abstract] [Full Text] [Related]

  • 12. [Salmonella of Indian origin: pseudo-susceptibility to fluoroquinolones].
    Denes E, Gondran G, Bezanahary H, Genet C, Rogez JP, Weinbreck P, Martin C.
    Med Mal Infect; 2005 Apr 18; 35(4):223-4. PubMed ID: 15914292
    [Abstract] [Full Text] [Related]

  • 13. Application of an in vitro infection model and simulation for reevaluation of fluoroquinolone breakpoints for Salmonella enterica serotype typhi.
    Booker BM, Smith PF, Forrest A, Bullock J, Kelchlin P, Bhavnani SM, Jones RN, Ambrose PG.
    Antimicrob Agents Chemother; 2005 May 18; 49(5):1775-81. PubMed ID: 15855495
    [Abstract] [Full Text] [Related]

  • 14. Nalidixic acid screening test in detection of decreased fluoroquinolone susceptibility in Salmonella typhi isolated from blood.
    Zafar A, Ibrahim NG, Ahsan T, Abbas Z, Zaidi A, Hasan R.
    J Coll Physicians Surg Pak; 2005 Jul 18; 15(7):413-7. PubMed ID: 16197870
    [Abstract] [Full Text] [Related]

  • 15. Multidrug-resistant typhoid fever in children: epidemiology and therapeutic approach.
    Gupta A.
    Pediatr Infect Dis J; 1994 Feb 18; 13(2):134-40. PubMed ID: 8190539
    [No Abstract] [Full Text] [Related]

  • 16. The treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever in Viet Nam.
    Parry CM.
    Trans R Soc Trop Med Hyg; 2004 Jul 18; 98(7):413-22. PubMed ID: 15138078
    [Abstract] [Full Text] [Related]

  • 17. Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime.
    Prabha Adhikari MR, Baliga S.
    J Assoc Physicians India; 2002 Mar 18; 50():428-9. PubMed ID: 11924574
    [No Abstract] [Full Text] [Related]

  • 18. Emerging drug resistance and vaccination for typhoid fever.
    Atkins BL, Gottlieb T.
    JAMA; 1998 Feb 25; 279(8):579; author reply 580. PubMed ID: 9486743
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.